JFG
KRYS icon

Jefferies Financial Group’s Krystal Biotech KRYS Stock Holding History

Jefferies Financial Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,200
Closed -$757K – 1590
2025
Q1 		$757K Buy
+4,200
New +$706K 0.01% 912
2024
Q1 		– Sell
-5,138
Closed -$637K – 1836
2023
Q4 		$637K Buy
+5,138
New +$570K ﹤0.01% 1122

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Jefferies Financial Group's KRYS Position: Q2 2025 in Review

Jefferies Financial Group sold out of Krystal Biotech (KRYS) in Q2 2025, closing a stake of 4,200 shares — an estimated $757K sold.

Jefferies Financial Group first reported a position in KRYS in Q4 2023 and held it in 2 quarters. The position peaked at $757K in Q1 2025. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2025.

  • Jefferies Financial Group reported no remaining Krystal Biotech position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 4,200 Krystal Biotech shares in Q2 2025, an estimated $757K.
  • Jefferies Financial Group first reported a position in Krystal Biotech in Q4 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Krystal Biotech position peaked at $757K in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.